Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Patients With ST-Segment Elevation Myocardial Infarction and Cerebrovascular Accidents: Impact of COVID-19 Vaccination on Mortality.
Cardiology research·2024
Related Experiment Video
Updated: May 10, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Common lung conditions: acute dyspnea.
1University of Kansas School of Medicine, 3901 Rainbow Blvd Mailstop 4010, Kansas City, KS 66160, USA. jdelzell@kumc.edu
FP Essentials
|June 18, 2013
Summary
Diagnosing acute dyspnea involves differentiating cardiac and respiratory causes. Biomarkers like BNP and NT-proBNP aid in ruling out heart failure, while D-dimer and imaging help identify pulmonary embolism.
Area of Science:
- Medical Science
- Clinical Medicine
- Pulmonology
Background:
- Dyspnea, a common symptom, presents diverse sensations and can indicate acute issues or exacerbations of chronic diseases like COPD and heart failure.
- Accurate differentiation between respiratory and cardiovascular origins of acute dyspnea is crucial for timely and effective management.
- End-of-life care also frequently involves patients experiencing dyspnea.
Observation:
- Biomarkers such as B-type natriuretic peptide (BNP) and N-terminal proB-type natriuretic peptide (NT-proBNP) are valuable in excluding heart failure as a cause of dyspnea.
- Clinical decision rules (e.g., Wells, Geneva) and D-dimer testing assist in diagnosing pulmonary embolism, with CT pulmonary angiography used for confirmation.
- Noninvasive positive pressure ventilation offers an alternative to mechanical ventilation for managing hypercapnic failure in chronic obstructive pulmonary disease exacerbations.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Findings:
- Elevated BNP/NT-proBNP levels are indicative of increased ventricular wall tension, common in heart failure exacerbations.
- A BNP level below 50 pg/mL demonstrates a 96% negative predictive value for ruling out heart failure.
- Diagnostic strategies for pulmonary embolism involve risk stratification followed by D-dimer testing or CT pulmonary angiography.
Implications:
- Updated diagnostic approaches improve the differentiation of acute dyspnea etiologies, leading to more precise treatment strategies.
- Understanding the utility of biomarkers and imaging techniques enhances the rapid diagnosis and management of critical conditions like pulmonary embolism.
- Noninvasive ventilation presents a significant advancement in managing acute respiratory failure, particularly for patients with specific care preferences.